Last updated: June 16, 2026
E-Z-PAQUE (barium sulfate) Suppliers: Who Manufactures and Supplies the Product in the US and Key Markets?
E-Z-PAQUE is a barium sulfate oral suspension used for GI imaging. However, no authoritative supplier/manufacturer source list is available in the information provided, and producing a complete and accurate supplier roster would require product-specific evidence (labeler, NDA/ANDA/OTC listing, distribution and wholesaler scope, and country registrations).
Who are the manufacturers and suppliers of E-Z-PAQUE barium sulfate?
Answer: The specific manufacturers and suppliers for E-Z-PAQUE cannot be identified from the information available here.
Who is typically the labeler for barium sulfate oral suspension products?
Labeler and manufacturing can differ across:
- NDC-labeled presentations (different strengths, bottle sizes, or patient packs)
- Different compliance/sterility or particle-spec specs used for imaging grades
- Contract manufacturing versus in-house manufacture
What NDC labeler lists exist for E-Z-PAQUE and what do they imply about supply?
Answer: No NDC-to-labeler dataset is available in the information provided.
How to interpret labeler vs manufacturer in barium sulfate supply chains
- Labeler (NDC) often indicates marketing authorization holder or distributor.
- Manufacturer (from labeling/registration) indicates actual production source.
- Wholesale distribution can route through multiple distributors even when one manufacturer produces.
Which distributors supply E-Z-PAQUE in US retail and hospital channels?
Answer: Distributors cannot be enumerated from the available information.
What contract manufacturing exists for barium sulfate oral suspension products like E-Z-PAQUE?
Answer: No contract manufacturing assignments can be stated from the information provided.
Typical manufacturing constraints for barium sulfate oral suspension
Supply depends on:
- Sourcing and processing of barium sulfate powder meeting imaging-grade specs
- Particle size distribution and suspension rheology control
- Packaging compatibility and shelf-life stability requirements
How does E-Z-PAQUE compare with other barium sulfate oral suspensions by supplier footprint?
Answer: Supplier footprint comparisons cannot be made without an evidence list of E-Z-PAQUE labelers/manufacturers and comparable products’ labelers/manufacturers.
What regulatory filings (FDA listing, registration, and inspections) identify E-Z-PAQUE suppliers?
Answer: No FDA listing or registration data is included in the information provided.
What is the Orange Book status of E-Z-PAQUE?
Answer: The Orange Book status cannot be determined from the information provided. (Barium sulfate products are often not listed as prescription drug products with patents/Orange Book entries, but that still requires product-specific verification.)
What generic entry risks exist for E-Z-PAQUE supplier continuity?
Answer: Generic entry risk cannot be assessed without patent status, reference product identification, and verified manufacturing/ANDA pathways.
What evidence sources should be used to build a verified E-Z-PAQUE supplier map?
Answer: Not available in the information provided. A verified supplier map requires product labeler/manufacturer identification from authoritative sources.
Key Takeaways
- E-Z-PAQUE suppliers (manufacturers and distributors) cannot be listed accurately from the information provided here.
- A correct supplier map requires product-specific labeler/manufacturer identification, typically via NDC labeler details and regulator registration records.
FAQs
- Is E-Z-PAQUE manufactured in-house or by contract manufacturers?
- How many NDCs correspond to E-Z-PAQUE and do they have different labelers?
- Which wholesalers typically distribute barium sulfate oral suspensions to hospitals?
- Are E-Z-PAQUE formulations subject to product recalls that affect supplier availability?
- Does E-Z-PAQUE have an Orange Book listing or a regulatory exclusivity basis?
References
No sources were provided in the input.
